Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 11(6): e0156857, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27271180

RESUMEN

Vitamin D is a fat-soluble steroid hormone that activates vitamin D receptor to regulate multiple downstream signaling pathways and transcription of various target genes. There is an association between vitamin D deficiency and increased risk for cardiovascular disease. However, most of the studies are observational and associative in nature with limited data on clinical application. Thus, there is a need for more prospective randomized controlled studies to determine whether or not vitamin D supplementation provides cardiovascular protection. In this study, we examined the effects of the deficiency and supplementation of vitamin D on coronary restenosis following coronary intervention in atherosclerotic Yucatan microswine. Twelve Yucatan microswine were fed vitamin D-deficient (n = 4) or -sufficient (n = 8) high cholesterol diet for 6-months followed by coronary intervention. Post-intervention, swine in the vitamin D-sufficient high cholesterol diet group received daily oral supplementation of either 1,000 IU (n = 4) or 3,000 IU (n = 4) vitamin D3. Six months later, optical coherence tomography (OCT) was performed to monitor the development of intimal hyperplasia and restenosis. Animals were euthanized to isolate arteries for histomorphometric and immunohistochemical studies. Animals had graded levels of serum 25(OH)D; vitamin D-deficient (15.33 ± 1.45 ng/ml), vitamin D-sufficient + 1,000 IU oral vitamin D post-intervention (32.27 ± 1.20 ng/ml), and vitamin D-sufficient + 3,000 IU oral vitamin D post-intervention (51.00 ± 3.47 ng/ml). Findings from the OCT and histomorphometric studies showed a decrease in intimal hyperplasia and restenosis in vitamin D-supplemented compared to vitamin D-deficient swine. Vitamin D supplementation significantly decreased serum levels of TNF-α and IFN-γ, upregulated serum levels of IL-10, and had no effect on serum IL-6 levels. These findings suggest that vitamin D supplementation limits neointimal formation following coronary intervention in atherosclerotic swine and provide the support for vitamin D supplementation to protect against the development of coronary restenosis.


Asunto(s)
Enfermedad de la Arteria Coronaria/cirugía , Reestenosis Coronaria/prevención & control , Intervención Coronaria Percutánea , Túnica Íntima/efectos de los fármacos , Túnica Íntima/patología , Deficiencia de Vitamina D/tratamiento farmacológico , Vitamina D/uso terapéutico , Animales , Enfermedad de la Arteria Coronaria/patología , Reestenosis Coronaria/etiología , Suplementos Dietéticos , Modelos Animales de Enfermedad , Hiperplasia/prevención & control , Intervención Coronaria Percutánea/efectos adversos , Porcinos , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/patología
2.
PLoS One ; 10(9): e0138539, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26382957

RESUMEN

Neointimal formation and cell proliferation resulting into in-stent restenosis is a major pathophysiological event following the deployment of stents in the coronary arteries. In this study, we assessed the degree of injury, based on damage to internal elastic lamina, media, external elastic lamina, and adventitia following the intravascular stenting, and its relationship with the degree of smooth muscle cell proliferation. We examined the smooth muscle cell proliferation and their phenotype at different levels of stent injury in the coronary arteries of domestic swine fed a normal swine diet. Five weeks after stent implantation, swine with and without stents were euthanized and coronaries were excised. Arteries were embedded in methyl methacrylate and sections were stained with H&E, trichrome, and Movat's pentachrome. The expression of Ki67, α-smooth muscle actin (SMA), vimentin, and HMGB1 was evaluated by immunofluorescence. There was a positive correlation between percent area stenosis and injury score. The distribution of SMA and vimentin was correlated with the degree of arterial injury such that arteries that had an injury score >2 did not have immunoreactivity to SMA in the neointimal cells near the stent struts, but these neointimal cells were positive for vimentin, suggesting a change in the smooth muscle cell phenotype. The Ki67 and HMGB1 immunoreactivity was highly correlated with the fragmentation of the IEL and injury in the tunica media. Thus, the extent of coronary arterial injury during interventional procedure will dictate the degree of neointimal hyperplasia, in-stent restenosis, and smooth muscle cell phenotype.


Asunto(s)
Actinas/metabolismo , Proliferación Celular/fisiología , Vasos Coronarios/metabolismo , Miocitos del Músculo Liso/metabolismo , Stents , Animales , Vasos Coronarios/citología , Vasos Coronarios/cirugía , Proteína HMGB1/metabolismo , Miocitos del Músculo Liso/citología , Neointima/metabolismo , Porcinos , Túnica Íntima/metabolismo
3.
PLoS One ; 7(8): e42789, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22880111

RESUMEN

BACKGROUND: Inflammatory cytokines, such as TNF-α, play a key role in the pathogenesis of occlusive vascular diseases. Activation of vitamin D receptors (VDR) elicits both growth-inhibitory and anti-inflammatory effects. Here, we investigated the expression of TNF-α and VDR in post-angioplasty coronary artery neointimal lesions of hypercholesterolemic swine and examined the effect of vitamin D deficiency on the development of coronary restenosis. We also examined the effect of calcitriol on cell proliferation and effect of TNF-α on VDR activity and expression in porcine coronary artery smooth muscle cells (PCASMCs) in-vitro. METHODOLOGY/PRINCIPAL FINDINGS: Expression of VDR and TNF-α and the effect of vitamin D deficiency in post-angioplasty coronary arteries were analyzed by immunohistochemistry and histomorphometry. Cell proliferation was examined by thymidine and BrdU incorporation assays in cultured PCASMCs. Effect of TNF-α-stimulation on the activity and expression of VDR was analyzed by luciferase assay, immunoblotting and immunocytochemistry. In-vivo, morphometric analysis of the tissues revealed typical lesions with significant neointimal proliferation. Histological evaluation showed expression of smooth muscle α-actin and significantly increased expression of TNF-α in neointimal lesions. Interestingly, there was significantly decreased expression of VDR in PCASMCs of neointimal region compared to normal media. Indeed, post-balloon angioplasty restenosis was significantly higher in vitamin D-deficient hypercholesterolemic swine compared to vitamin D-sufficient group. In-vitro, calcitriol inhibited both serum- and PDGF-BB-induced proliferation in PCASMCs and TNF-α-stimulation significantly decreased the expression and activity of VDR in PCASMCs. CONCLUSIONS/SIGNIFICANCE: These data suggest that significant downregulation of VDR in proliferating smooth muscle cells in neointimal lesions could be due to atherogenic cytokines, including TNF-α. Vitamin D deficiency potentiates the development of coronary restenosis. Calcitriol has anti-proliferative properties in PCASMCs and these actions are mediated through VDR. This could be a potential mechanism for uncontrolled growth of neointimal cells in injured arteries leading to restenosis.


Asunto(s)
Angioplastia Coronaria con Balón/efectos adversos , Aterosclerosis/terapia , Vasos Coronarios/patología , Vasos Coronarios/cirugía , Neointima/etiología , Neointima/patología , Receptores de Calcitriol/metabolismo , Animales , Apoptosis/efectos de los fármacos , Aterosclerosis/sangre , Aterosclerosis/patología , Becaplermina , Calcitriol/farmacología , Proliferación Celular/efectos de los fármacos , Reestenosis Coronaria/sangre , Reestenosis Coronaria/etiología , Reestenosis Coronaria/patología , Vasos Coronarios/efectos de los fármacos , Modelos Animales de Enfermedad , Técnicas de Silenciamiento del Gen , Hiperplasia , Lípidos/sangre , Miocitos del Músculo Liso/efectos de los fármacos , Miocitos del Músculo Liso/patología , Neointima/sangre , Proteínas Proto-Oncogénicas c-sis/farmacología , ARN Interferente Pequeño/metabolismo , Receptores de Calcitriol/genética , Sus scrofa/cirugía , Transcripción Genética/efectos de los fármacos , Factor de Necrosis Tumoral alfa/farmacología , Vitamina D/metabolismo
4.
Exp Mol Pathol ; 91(1): 346-52, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21540027

RESUMEN

AIMS: The growth and differentiation of cells is regulated by cytokines by binding to cell-surface receptors and activating intracellular signal transduction cascade. Suppressor of cytokine signaling (SOCS)-3 is a negative regulator of cytokines. In this study we examined the expression of SOCS-3 in porcine coronary artery smooth muscle cells (PCASMCs) in vitro and in proliferating smooth muscle cells of neointimal lesions after coronary artery intervention in a swine model. METHODS AND RESULTS: PCASMCs were cultured and stimulated with TNF-α and/or IGF-1 individually or in combination. Protein expression of SOCS-3 was examined using Western blot. For in vivo studies, six female Yucatan miniswine were fed with special high cholesterol diet for 8 months. At 4 months of high cholesterol diet, animals underwent coronary balloon angioplasty. At the end of 8 months animals were euthanized, coronary arteries were isolated and morphological and histological studies were performed. Western blot data revealed significantly high SOCS-3 expression in PCASMCs in the presence of either TNF-α or IGF-1 (5-6 fold) alone. However, in the presence of both TNF-α and IGF-1 the SOCS-3 expression was significantly decreased (4-5 fold). Results from morphological studies including, H&E and Masson's trichrome stain showed typical lesions with significant neointimal proliferation. Histological evaluation showed expression of smooth muscle α-actin and significantly increased proliferating cell nuclear antigen (PCNA) in neointimal lesion. Interestingly, there was significantly decreased expression of SOCS-3 in smooth muscle cells of neointima as compared to control. CONCLUSIONS: These data suggest that SOCS-3 expression is decreased in proliferating smooth muscle cells of neointimal lesions. This leads to uncontrolled growth of vascular smooth muscle cells in injured arteries leading to restenosis. Therefore, local delivery of SOCS-3 gene at the site of injury after coronary artery intervention could regulate the proliferation of vascular smooth muscle cells and help in preventing the neointimal hyperplasia and restenosis.


Asunto(s)
Angioplastia Coronaria con Balón/efectos adversos , Vasos Coronarios/patología , Músculo Liso Vascular/patología , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Túnica Íntima/patología , Actinas/metabolismo , Animales , Proliferación Celular , Células Cultivadas , Colesterol en la Dieta/administración & dosificación , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/lesiones , Vasos Coronarios/metabolismo , Modelos Animales de Enfermedad , Femenino , Hiperplasia , Factor I del Crecimiento Similar a la Insulina/farmacología , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/lesiones , Músculo Liso Vascular/metabolismo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Porcinos , Porcinos Enanos , Factor de Necrosis Tumoral alfa/farmacología , Túnica Íntima/efectos de los fármacos , Túnica Íntima/lesiones , Túnica Íntima/metabolismo
5.
Can J Physiol Pharmacol ; 83(8-9): 701-15, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16333372

RESUMEN

Atherosclerosis and restenosis are the result of vascular injury followed by an inflammatory and fibroproliferative response that involves a large number of growth factors, cytokines, and cellular elements. Platelet activation and leukocyte recruitment into the arterial intima play a crucial role, initiating a whole spectrum of reactions leading to vascular smooth muscle cell hyperplasia and intimal migration. The roles of macrophages and lymphocytes and mast cells as mediators of inflammation and immune response is discussed, as are the roles of growth factors and cytokines. New light on the 'old' problems will help us to devise newer and better therapeutic strategies to combat these clinical entities.


Asunto(s)
Aterosclerosis , Reestenosis Coronaria , Oclusión de Injerto Vascular , Animales , Citocinas , Sustancias de Crecimiento , Humanos , Inmunidad Celular , Leucocitos , Macrófagos , Mastocitos , Miocitos del Músculo Liso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA